Effective control in MSI-high unresectable intrahepatic cholangiocarcinoma treated with gemcitabine/cisplatin/durvalumab and proton beam therapy: a case report.

Saved in:
Bibliographic Details
Title: Effective control in MSI-high unresectable intrahepatic cholangiocarcinoma treated with gemcitabine/cisplatin/durvalumab and proton beam therapy: a case report.
Authors: Nosaka T; Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan., Naito H; Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan., Murata Y; Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan., Akazawa Y; Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan., Tanaka T; Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan., Takahashi K; Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan., Naito T; Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan., Ohtani M; Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan., Imamura Y; Division of Diagnostic Pathology/Surgical Pathology, University of Fukui Hospital, Fukui, Japan., Nakamoto Y; Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Source: Frontiers in immunology [Front Immunol] 2025 Oct 23; Vol. 16, pp. 1685944. Date of Electronic Publication: 2025 Oct 23 (Print Publication: 2025).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2025.1685944